Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica

Bray, 1998, Definitions and proposed current classifications of obesity, 31 1996, Med Clin (Barc), 107, 782 WHO. Programme of Nutrition, Family and Reproductive Health. Obesity. Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, 3-5 June, 1997. Geneva: WHO; 1998. Cole, 2000, Establishing a standard definition for child overweight and obesity worldwide: international survey, BMJ, 320, 1240, 10.1136/bmj.320.7244.1240 Serra-Majem, 2003, Obesidad infantil y juvenil en España. Resultados del estudio enKid (1998-2000), Med Clin (Barc), 121, 725, 10.1016/S0025-7753(03)74077-9 Aranceta Bartrina, 2005, Prevalencia de obesidad en España, Med Clin (Barc), 125, 460, 10.1157/13079612 Rubio, 2006, Prevalencia de obesidad en España tras 14 años de seguimiento de la cohorte DRECE, Endocr Nutr, 53, 86 Gutiérrez-Fisac, 2005, Prevalencia de obesidad en la población adulta española: 14 años de crecimiento continuado, Med Clin (Barc), 124, 196, 10.1157/13071485 Gutierrez-Fisac, 2004, Prevalence of overweight and obesity in elderly people in Spain, Obes Res, 12, 710, 10.1038/oby.2004.83 Aranceta, 2004, Perfil nutricional de los ancianos institucionalizados en España Aranceta Bartrina, 2001, Factores determinantes de la obesidad en la población infantil y juvenil española, 109 Aranceta, 2001, Influence of sociodemographic factors in the prevalence of obesity in Spain. The SEEDO’97 Study, Eur J Clin Nutr, 55, 430, 10.1038/sj.ejcn.1601189 Gutiérrez-Fisac, 2002, The size of obesity differences associated with educational level in Spain, 1987 and 1995/97, J Epidemiol Community Health, 56, 457, 10.1136/jech.56.6.457 Onat, 2004, Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk, Int J Obes Relat Metab Disord, 28, 1018, 10.1038/sj.ijo.0802695 Grundy, 2005, Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 Alberti, 2005, The metabolic syndrome – A new worldwide difinition, Lancet, 366, 1059, 10.1016/S0140-6736(05)67402-8 García-Lorda, 2006, C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population, Int J Obes, 30, 468, 10.1038/sj.ijo.0803182 Eckel, 2005, The metabolic syndrome, Lancet, 365, 1415, 10.1016/S0140-6736(05)66378-7 Ford, 2002, Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey, JAMA, 287, 356, 10.1001/jama.287.3.356 Martínez-Larrad, 2005, Prevalencia del síndrome metabólico (criterios ATP-III). Estudio de base poblacional en áreas rural y urbana de la provincia de Segovia, Med Clin (Barc), 125, 481, 10.1157/13080210 Lorenzo, 2003, Central adiposity determines prevalence differences of the metabolic syndrome, Obes Res, 11, 1480, 10.1038/oby.2003.198 Álvarez León, 2003, Prevalencia del síndrome metabólico en la población de la Comunidad Canaria, Med Clin (Barc), 120, 172, 10.1157/13043145 Ascaso, 2003, Abdominal obesity, insulin-resistance, and metabolic syndrome in a southern European population, Eur J Intern Med, 14, 101, 10.1016/S0953-6205(03)00022-0 Troiano, 1996, The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies, Int J Obes Relat Metab Disord, 20, 63 Manson, 1987, Body weight and longevity. A reassessment, JAMA, 257, 353, 10.1001/jama.257.3.353 Bautista-Castaño, 2003, Factores de riesgo cardiovascular en el sobrepeso y la obesidad: variaciones tras tratamiento de pérdida ponderal, Med Clin (Barc), 121, 485, 10.1157/13053138 Athyros, 2004, Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes melliuts: the METSGREECE multicentre study, Curr Med Res Opin, 20, 1691, 10.1185/030079904X5599 Stevens, 1998, The effect of age on the association between body-mass index and mortality, N Engl J Med, 338, 1, 10.1056/NEJM199801013380101 Ajani, 2004, Body mass index and mortality among US male physicians, Ann Epidemiol, 14, 731, 10.1016/j.annepidem.2003.10.008 Blackberry, 2004, Body mass index is not a significant predictor of survival amongst older people, Asia Pac J Clin Nutr, 137 Heiat, 2001, An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons, Arch Intern Med, 16, 1194, 10.1001/archinte.161.9.1194 Elia, 2001, Obesity in the elderly, Obes Res, 9, 244, 10.1038/oby.2001.126 National Heart Lung and Blood Institute: Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res. 1998;6:S51-S210. Avenell, 2004, What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials, J Hum Nutr Diet, 17, 317, 10.1111/j.1365-277X.2004.00531.x Nordmann, 2006, Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors. A meta-analysis of randomized controlled trials, Arch Intern Med, 166, 285, 10.1001/archinte.166.3.285 Pirozzo, 2003, Should we recommend low-fat diets for obesity?, Obes Rev, 4, 83, 10.1046/j.1467-789X.2003.00099.x Dansinger, 2005, Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial, JAMA, 293, 43, 10.1001/jama.293.1.43 Riccardi, 2004, Dietary fat, insulin sensitivity and the metabolic syndrome, Clin Nutr, 23, 447, 10.1016/j.clnu.2004.02.006 Mustajoki, 2001, Very low energy diets in the treatment of obesity, Obes Res, 2, 61, 10.1046/j.1467-789x.2001.00026.x Lantz, 2003, Intermittent versus on-demand use of a very low caloric diet: a randomized 2-year clinical trial, J Int Med, 253, 463, 10.1046/j.1365-2796.2003.01131.x Garrow, 1995, Meta-analysis: effects of exercise, with or without dieting, on body composition of overweight subjects, Eur J Clin Nutr, 49, 1 Miller, 1997, A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention, Int J Obes, 21, 941, 10.1038/sj.ijo.0800499 Jakicic, 2005, Physical activity considerations for the treatment and prevention of obesity, Am J Clin Nutr, 82, 226, 10.1093/ajcn/82.1.226S Pate, 1995, Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine, JAMA, 273, 402, 10.1001/jama.273.5.402 US Department of Health and Human Services and U.S. Department of Agriculture. Dietary Guidelines for Americans 2005 [consultado 25/06/2006]. Disponible en: www.healthierus.gov/dietaryguidelines Saris, 2003, How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement, Obes Rev, 4, 101, 10.1046/j.1467-789X.2003.00101.x Jakicic, 2001, American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults, Med Sci Sports Exerc, 33, 2145, 10.1097/00005768-200112000-00026 Jeffery, 2003, Physical activity and weight loss: does prescribing higher physical activity goals improve outcome?, Am J Clin Nutr, 78, 684, 10.1093/ajcn/78.4.684 Wadden, 2004, Lifestyle modification in the management of obesity, J Gastroenterol, 7, 452 Foster, 2005, Behavioral treatment of obesity, Am J Clin Nutr, 82, 230, 10.1093/ajcn/82.1.230S Wadden, 2005, Randomized trial of lifestyle modification and pharmacotherapy for obesity, N Engl J Med, 353, 2111, 10.1056/NEJMoa050156 Guerciolini, 1997, Mode of acting of orlistat, Int J Obes Relat Metab Disord, 1, 12 Hutton, 2004, Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials, Am J Clin Nutr, 80, 1461, 10.1093/ajcn/80.6.1461 O’Meara, 2004, A systematic review of the clinical effectiveness of orlistat used for the management of obesity, Obes Rev, 5, 51, 10.1111/j.1467-789X.2004.00125.x Padwall, 2003, Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials, Int J Obes, 27, 1437, 10.1038/sj.ijo.0802475 Li, 2005, Meta-analysis: pharmacologic treatment of obesity, Ann Intern Med, 142, 532, 10.7326/0003-4819-142-7-200504050-00012 Norris, 2004, Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis, Arch Intern Med, 164, 1395, 10.1001/archinte.164.13.1395 Torgerson, 2004, Xenical in the prevention of diabetes in obese subjects (XENDOS) Study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients, Diabetes Care, 27, 155, 10.2337/diacare.27.1.155 Mittendorfer, 2001, Orlistat inhibits dietary cholesterol absorption, Obes Res, 9, 599, 10.1038/oby.2001.79 Hsieh, 2005, Orlistat for obesity: benefits beyond weight loss, Diabetes Res Clin Pract, 67, 78, 10.1016/j.diabres.2004.05.012 Tiikkainen, 2004, Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women, Am J Clin Nutr, 79, 22, 10.1093/ajcn/79.1.22 Kelley, 2004, Effects of moderate weight loss on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes, Diabetes Care, 27, 33, 10.2337/diacare.27.1.33 Zelber-Sagi, 2006, A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 4, 639, 10.1016/j.cgh.2006.02.004 Sutera, 2005, Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size, Atherosclerosis, 180, 127, 10.1016/j.atherosclerosis.2004.11.023 Hansen, 1998, Thermogenic effects of sibutramine in humans, Am J Clin Nutr, 68, 1180, 10.1093/ajcn/68.6.1180 Arterburn, 2004, The efficacy and safety of sibutramine for weight loss: a systematic review, Arch Intern Med, 164, 994, 10.1001/archinte.164.9.994 Milano, 2005, Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study, Adv Ther, 22, 25, 10.1007/BF02850181 Apfelbaum, 1999, Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine, Am J Med, 106, 179, 10.1016/S0002-9343(98)00411-2 Mathus-Vliegen, 2005, Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study, Eur J Clin Nutr, 59, 31, 10.1038/sj.ejcn.1602172 James, 2000, Effect of sibutramine on weight maintenance after weight loss: a randomized trial. STORM Study Group (Sibutramine Trial of Obesity Reduction and Maintenance), Lancet, 356, 2119, 10.1016/S0140-6736(00)03491-7 Gaciong, 2005, Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study, J Hum Hypertens, 19, 737, 10.1038/sj.jhh.1001877 DiMarzo, 2005, Endocannabinoid control of food intake and energy balance, Nat Neurosc, 8, 585, 10.1038/nn1457 VanGaal, 2005, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study, Lancet, 365, 1389, 10.1016/S0140-6736(05)66374-X Despres, 2005, Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia, N Engl J Med, 353, 2121, 10.1056/NEJMoa044537 Pi-Sunyer, 2006, Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial, JAMA, 295, 761, 10.1001/jama.295.7.761 Scheen, 2005 Gelfnad, 2006, Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors, J Am Coll Cardiol, 47, 1919, 10.1016/j.jacc.2005.12.067 De Villar, 2003, Tratamientos «alternativos» de la obesidad: mito y realidad, Med Clin (Barc), 121, 500, 10.1157/13053141 Pittler, 2005, Complementary therapies for reducing body weight: a systematic review, Int J Obes, 25, 1030, 10.1038/sj.ijo.0803008 Pories, 1992, Surgical treatment of obesity and its effect on diabetes: 10-y follow-up, Am J Clin Nutr, 55, 582, 10.1093/ajcn/55.2.582s Sjöström, 1999, Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study, Obes Res, 7, 477, 10.1002/j.1550-8528.1999.tb00436.x Sjostrom, 2004, Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery, N Engl J Med, 351, 2683, 10.1056/NEJMoa035622 Buchwald, 2004, Bariatric Surgery: a systematic review and meta-analysis, JAMA, 292, 1724, 10.1001/jama.292.14.1724 Maggard, 2005, Meta-analysis: surgical treatment of obesity, Ann Intern Med, 142, 547, 10.7326/0003-4819-142-7-200504050-00013 Rubio, 2004, Documento de consenso sobre cirugía bariátrica, Rev Esp Obes, 4, 223 Baltasar, 1998, Vertical banded gastroplasty at more than five years, Obes Surg, 8, 29, 10.1381/096089298765555015 Arribas del Amo, 2001, Resultados a largo plazo de la gastroplastia vertical con banda en el tratamiento quirúrgico de la obesidad mórbida. Complicaciones específicas de la técnica quirúrgica, Cir Esp, 70, 227, 10.1016/S0009-739X(01)71887-8 Dargent, 1999, Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution, Obes Surg, 9, 446, 10.1381/096089299765552729 Vetruyen, 2002, Experience with lap-band system up to 7 years, Obes Surg, 12, 569, 10.1381/096089202762252361 Brolin, 2001, Gastric bypass, Surg Clin North Am, 81, 1077, 10.1016/S0039-6109(05)70185-7 Wittgrove, 2000, Laparoscopic gastric bypass, Roux-en-Y 500 patients: technique and results, with 3-60 month follow-up, Obes Surg, 10, 233, 10.1381/096089200321643511 Nguyen, 2001, Laparoscopic versus open gastric bypass: a randomised study of outcomes, quality of life and costs, Ann Surg, 234, 279, 10.1097/00000658-200109000-00002 Podnos, 2003, Complications alter laparoscopic gastric bypass, Arch Surg, 138, 957, 10.1001/archsurg.138.9.957 Scopinaro, 1998, Biliopancreatic diversion, World J Surg, 22, 936, 10.1007/s002689900497 Baltasar, 2004, Cruce duodenal, Cir Esp, 75, 259, 10.1016/S0009-739X(04)72316-7 Sánchez-Cabezudo, 2001, Resultados a 5 años de la derivación biliopancreática de Larrad en el tratamiento de la obesidad mórbida, Cir Esp, 70, 133, 10.1016/S0009-739X(01)71863-5 Bloomberg, 2005, Nutritional deficiencies following bariatric surgery: what have we learned?, Obes Surg, 15, 145, 10.1381/0960892053268264 Genco, 2005, BioEnterics intragastric balloon: the Italian experience with 2,515 patients, Obes Surg, 15, 1161, 10.1381/0960892055002202 Genco, 2006, BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients, Int J Obes, 30, 129, 10.1038/sj.ijo.0803094 Mathus-Vliegen, 2005, Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up, Gastrointest Endosc, 61, 19, 10.1016/S0016-5107(04)02406-X Herve, 2005, What becomes of patients one year after the intragastric balloon has been removed?, Obes Surg, 15, 864, 10.1381/0960892054222894 Alfalah, 2006, Intragastric balloon for preoperative weight reduction in candidates for laparoscopic gastric bypass with massive obesity, Obes Surg, 16, 147, 10.1381/096089206775565104 Chen, 2004, Mechanisms of action of the implantable gastric stimulator for obesity, Obes Surg, 14, S28, 10.1381/0960892041978962 Himes, 1994, Guidelines for overweight in adolescent preventive services: recommendations from an expert committee, Am J Clin Nutr, 59, 307, 10.1093/ajcn/59.2.307 Moore, 1995, Preschool physical activity level and change in body fatness in young children. The Framinghan children’s Study, Am J Epidemiol, 142, 982, 10.1093/oxfordjournals.aje.a117747 Neumark-Sztainer, 2004, Weight-control behaviors among adolescent girls and boys: implications for dietary intake, J Am Diet Assoc, 104, 913, 10.1016/j.jada.2004.03.021 Sothern, 2003, Prevention of obesity in young children: a critical challenge for medical professionals, Clin Pediatr, 42, 101, 10.1177/000992280304200202 McLean, 2003, Family involvement in weight control, weight maintenance and weight-loss interventions: a systematic review of randomised trials, Int J Obes, 27, 987, 10.1038/sj.ijo.0802383 2003, Policy Statement. Committee on Nutrition. Prevention of Pediatric Overweight and Obesity, Pediatrics, 112, 424, 10.1542/peds.112.2.424 Fitzgibbon, 2004, Environmental changes. May be needed for prevention of overweight in minority children, Pediatric Ann, 33, 45, 10.3928/0090-4481-20040101-12 Gross, 2004, Coordinated school heath program and dietetics professionals: Partners in promoting healthful eating, J Am Diet Assoc, 104, 739, 10.1016/j.jada.2004.02.024 Lobstein, 2004, Obesity in children and young people: a crisis in public health, Obes Rev, 5, 4, 10.1111/j.1467-789X.2004.00133.x López de la Torre, 2004, Internet y endocrinología, Endocr Nutr, 51, 67, 10.1016/S1575-0922(04)74587-8 Tirodkar, 2003, Food messages on African American television shows, Am J Public Health, 93, 439, 10.2105/AJPH.93.3.439 Allison, 2003, Treatment and prevention of obesity: what works, what doesn’t work, and what might work, Lipids, 38, 147, 10.1007/s11745-003-1045-5 OMS. Estrategia mundial sobre régimen alimentario, actividad física y salud. 57.ª Asamblea Mundial de la Salud 2004 [consultado 25/06/2006]. Disponible en: http://www.who.int/dietphysicalactivity/en/ 2005